glaucoma treatment

Examining causes, treatment and prevention of glaucoma

harminka — Thu, 05 Mar 2009 05:05:38 -0600

Although scientists know progressive degeneration of retinal ganglion cells and their axons is the primary cause of glaucoma, researchers have yet to identify a way to stop or prevent the degeneration.

Cost of glaucoma medications may impact treatment

harminka — Fri, 28 Dec 2007 07:47:15 -0600

In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38% to 52% of the total.

Cause of major subtype of glaucoma discovered

harminka — Fri, 10 Aug 2007 00:19:48 -0500

In a paper published in the journal Science, scientists from deCODE genetics and academic colleagues from the National University Hospital in Reykjavik and Uppsala University in Sweden report the discovery of two common single letter variations (SNPs) in the sequence of the human genome that appear to account for virtually all cases of a major subtype of glaucoma.

Miniature implanted devices could treat epilepsy, glaucoma

harminka — Wed, 08 Aug 2007 04:53:33 -0500

Purdue University researchers have developed new miniature devices designed to be implanted in the brain to predict and prevent epileptic seizures and a nanotech sensor for implantation in the eye to treat glaucoma.

New Alzheimer's treatments may help treat major eye disease

harminka — Tue, 07 Aug 2007 04:12:06 -0500

UK scientists have shown for the first time that key proteins involved in Alzheimer's disease are also implicated in glaucoma, the major cause of irreversible blindness worldwide. Research carried out at the UCL Institute of Ophthalmology and funded by the Wellcome Trust has also shown that novel drugs being trialled for Alzheimer's disease which target this protein may be used to treat glaucoma.

New promise for glaucoma treatment

harminka — Thu, 02 Aug 2007 07:53:36 -0500

Iowa State University researchers have developed a new technique that successfully treated rats for blindness caused by glaucoma. Their experimental treatment will be used on canine patients in the next year. If successful, it is expected to move to human trials.

Nanoparticle Offers Promise for Treating Glaucoma

harminka — Tue, 19 Jun 2007 01:25:21 -0500

A unique nanoparticle made in a laboratory at the University of Central Florida is proving promising as a drug delivery device for treating glaucoma, an eye disease that can cause blindness and affects millions of people worldwide.